在移植患者中,提科普拉宁的群体药理动力学和剂量优化
Yangang Zhou1,2, Jiawei Peng3, Ping Xu1,2
1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Antimicrobial agents and chemotherapy
|April 23, 2025
概括
对于移植患者来说,最佳的提科普拉宁剂量需要个性化方案. 标准剂量是不够的;基于肌素清除量的剂量确保了足够的药物暴露和治疗成功.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
背景情况:
- 泰科普拉宁是一种用于治疗感染的抗生素.
- 接受脏移植的接受者往往需要谨慎的药物管理,因为改变了生理.
- 优化抗生素剂量对于有效性和最大限度地减少耐药性至关重要.
研究的目的:
- 在移植患者中表征teicoplanin的群体药理动力学 (PK).
- 为此群体推最佳的提科普拉宁剂量策略.
- 确保足够的药物暴露和治疗目标得到满足.
主要方法:
- 来自99名移植患者的386个血样本的人口药理动力学分析.
- 利用一个双隔间的PK模型来描述teicoplanin的配置.
- 进行模拟以确定剂量方案以达到目标 (>15微克/毫升最低值,AUC/MIC>610.4).
主要成果:
- 鉴定出肌素清除率 (CrCL) 是唯一影响泰克托普拉宁清除率的有意义共变量.
- 在许多患者中,标准的提科普拉宁剂量方案被发现不足以实现治疗目标.
- 该PK模型估计清除值为0.711 L/h,Vc为11.3 L,Q为4.22 L/h,Vp为35.2 L.
结论:
- 建议对移植患者进行个性化,基于CrCL的剂量方案,用于teicoplanin的加载剂量和维持剂量.
- 可能需要高于标准的提科普拉宁剂量来实现快速和适当的药物暴露.
- 优化剂量策略对于在这个脆弱的患者群体中有效的tiacoplanin治疗至关重要.
相关概念视频
Renal Failure: Dose Adjustments
45
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
45
Drug Elimination by Renal Route: Tubular Secretion
2.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K
Renal Drug Excretion: Tubular Secretion
98
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
98
Nonlinear Pharmacokinetics: Overview
214
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
214
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.7K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.7K


